D.E. Shaw & Co
ETON icon

D.E. Shaw & Co’s Eton Pharmaceutcials ETON Stock Holding History

D.E. Shaw & Co’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,331
Closed -$259K – 4675
2025
Q4 		$259K Buy
+15,331
New +$270K ﹤0.01% 4221
2021
Q1 		– Sell
-10,209
Closed -$83K – 4168
2020
Q4 		$83K Buy
+10,209
New +$78.8K ﹤0.01% 3830

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

D.E. Shaw & Co's ETON Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 15,331 shares — an estimated $259K sold.

D.E. Shaw & Co first reported a position in ETON in Q4 2020 and held it in 2 quarters. The position peaked at $259K in Q4 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 15,331 Eton Pharmaceutcials shares in Q1 2026, an estimated $259K.
  • D.E. Shaw & Co first reported a position in Eton Pharmaceutcials in Q4 2020 and held it in 2 quarters.
  • D.E. Shaw & Co's Eton Pharmaceutcials position peaked at $259K in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.